Dr. Trymore Magomana, MBA
Executive Regulatory Affairs Leader | Global Market Access | Quality Governance | Portfolio Risk
I guide medical device organizations through the intersection of regulatory strategy, clinical evidence, quality governance, and commercial execution. My focus is building scalable regulatory operating models, strengthening executive decision-making, and enabling sustainable global market access across complex product portfolios.
A Regulatory Leader Built Across the Full Device Lifecycle
Dr. Trymore Magomana is a regulatory affairs and medical device leader with more than fifteen years of experience across multinational, mid-size, consulting, and growth-stage organizations. His career spans global regulatory strategy, clinical and post-market governance, quality systems, standards, product lifecycle management, and direct engagement with health authorities and notified bodies.
He has supported Class I, II, and III medical devices across product development, submissions, manufacturing and facility changes, global registrations, labeling, clinical evidence, vigilance, complaint assessment, and inspection readiness. His operating perspective is shaped by hands-on technical depth and by the executive discipline required to translate regulatory complexity into business-relevant decisions.
Dr. Magomana combines regulatory expertise with training in global health, business strategy, bioethics, and biology. This multidisciplinary foundation supports a leadership approach that is systems-oriented, commercially aware, patient-centered, and grounded in disciplined execution.
Progressive Leadership Across Global Medical Devices
Manager, Global Regulatory & Clinical Affairs and Vigilance
Ambu A/SDirecting regulatory, clinical, vigilance, registration, labeling, and lifecycle governance across the United States, Canada, Europe, the United Kingdom, Latin America, and Asia-Pacific. Advising leadership on regulatory risk, submissions, post-market obligations, and cross-functional execution.
Regulatory Affairs Leadership
Cook Medical & CVRxLed EU MDR transition work, PMA and IDE lifecycle activity, clinical and post-market deliverables, regulatory assessments, FDA and notified body engagement, and complex Class II and III device strategy.
Global Regulatory Strategy & Lifecycle Management
Abbott & BaxterSupported global submissions, manufacturing and product-change assessments, labeling, UDI, quality systems, risk management, post-market surveillance, and market-maintenance activities across highly regulated device portfolios.
Senior Management Consultant, Global Life Sciences
Wipro TechnologiesAdvised multinational life sciences organizations on global regulatory strategy, quality systems, EU MDR transformation, submissions, clinical evidence, risk management, labeling, regulatory intelligence, and operating-model improvement.
Regulatory Affairs & Quality Engineer
Intertek GroupBuilt an early technical foundation in electrical safety, essential performance, IEC 60601-1, ISO 14971, certification, testing, auditing, and global product compliance.
Executive Regulatory Expertise
Global Market Access
Regulatory pathway strategy, market sequencing, international registrations, evidence alignment, and lifecycle planning across major global markets.
Health Authority Engagement
FDA and notified body interactions, Q-Subs and pre-submissions, deficiency responses, change notifications, and regulator-facing technical communication.
Portfolio Risk Governance
Translating complaints, vigilance, CAPA, risk management, clinical evidence, and product changes into clear executive decisions and escalation pathways.
Operating Model Design
Regulatory governance, decision rights, team structures, regulatory operations, submission management, and scalable cross-functional execution.
Clinical & Post-Market Strategy
Clinical evaluations, PMCF, PMS, PSURs, vigilance, IDE and PMA lifecycle support, safety-signal assessment, and benefit-risk integration.
Leadership & Talent
Building high-performing teams, clarifying accountability, mentoring regulatory talent, and creating disciplined execution rhythms without unnecessary escalation.
Calm, Decisive, Cross-Functional Leadership
Strategic Clarity
Define the regulatory pathway, decision criteria, evidence expectations, and material trade-offs before teams enter execution.
Operational Discipline
Establish ownership, timelines, escalation routes, and governance mechanisms that make delivery predictable and defensible.
Constructive Challenge
Surface risk early, resolve ambiguity directly, and maintain a low-drama environment where teams can make high-quality decisions.
Enterprise Alignment
Connect regulatory strategy with clinical, quality, operations, commercial priorities, patient safety, and long-term portfolio value.
Multidisciplinary Preparation for Enterprise Leadership
Global Health Systems
Indiana University
International Business & Strategy
University of Illinois Urbana-Champaign
Bioethics & Health Policy
Loyola University Chicago
Biology
Grinnell College
Regulatory Affairs Certification
Medical-device regulatory practice
Project Management Professional
Enterprise execution and governance
Executive Regulatory Insights
Risk Intelligence for Device Leaders
Turning fragmented regulatory and quality signals into timely executive decisions.
Market AccessNavigating Complex Global Submissions
Sequencing markets, evidence, governance, and execution across global portfolios.
GovernanceExecutive Decisions in Device Compliance
How leadership choices shape compliance resilience, credibility, and enterprise risk.
Regulatory leadership built for complex portfolios and consequential decisions.
Review the executive profile for a focused view of leadership scope, operating model, governance philosophy, and global regulatory capability.